What Are Exceptional Responders?
When a clinical trial of a new drug fails because most patients don’t respond, progress can still be made by analyzing the tumors of the rare patients who benefit.
Tuesday, March 24, 2015
Five Fascinating Approaches to Cancer Science
From tropical plants and 3-D snapshots of worms to tiny particles that light up tumors, here’s a glimpse at some of the fascinating work MSK researchers pursued in 2014 as part of our quest to advance cancer science.
Tuesday, December 30, 2014